Therefore, poor antiviral effect, decompensation of liver function, large primary liver cancer, and late clinical stage are not only the factors for Hsp90α overexpression but also the adverse factors for liver cancer prognosis [2, 22–26]. The gene discussed is HSP90AA1; the disease is liver cancer.